Sars-Cov-2主蛋白酶配体的设计与对接-中国期刊网

摘要摘要:严重急性呼吸系统综合征(SARS)的流行表明，人畜共患病向人类和动物冠状病毒(COV)的传播对公众健康构成严重威胁，因此有必要制定防治对策。由于缺乏对SARS-CoV-2引起的COVID-19的有效治疗，为了开发更有效的抑制剂，我们发现非共价片段X1249的设计提供了进一步的有益信息。

1郭春旭,闫莉. SARS-CoV-2感染与宿主免疫反应.医药卫生,2022-12.
2Dawid Maciorowski,Divakar Sharma,Adinarayana Kunamneni. Environmental factors and their role in the transmission of SARS-CoV-2.医药卫生,2021-11.
3Xie Zhengde. Pay attention to SARS-CoV-2 infection in children.医药卫生,2020-08.
4Wang Xiaolin,Gui Jingang. Cell-mediated immunity to SARS-CoV-2.医药卫生,2021-02.
5Weijing Yuan,Xiaojing Dong,Lan Chen,Xiaobo Lei,Zhuo Zhou,Li Guo,Jianwei Wang. Screening for inhibitors against SARS-CoV-2 and its variants.医药卫生,2022-12.
6Fu Li,Zhichao Liang,Shujuan Cui,Bing Lv,Zhaomin Feng,Hui Xu,Lei Jia,Peng Yang,Quanyi Wang,Yang Pan,Daitao Zhang. Importation of SARS-CoV-2 Omicron variant in Beijing, China.医药卫生,2022-12.
7Zhaomin Feng,Shujuan Cui,Bing Lyu,Zhichao Liang,Fu Li,Lingyu Shen,Hui Xu,Peng Yang,Quanyi Wang,Daitao Zhang,Yang Pan. Genomic characteristics of SARS-CoV-2 in Beijing, China, 2021.医药卫生,2022-12.
8Badaoui Bouabid,Sadki Khalid,Talbi Chouhra,Salah Driss,Tazi Lina. Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco.医药卫生,2021-06.
9Xu Jianqing. SARS-CoV-2: an unknown agent and challenges in vaccine development.医药卫生,2020-08.
10Filippatos Filippos,Tatsi Elizabeth-Barbara,Michos Athanasios. Immune response to SARS-CoV-2 in children: A review of the current knowledge.医药卫生,2021-10.

Sars-Cov-2主蛋白酶配体的设计与对接